clinical trial · NCT07269756
A Study to Evaluate the Drug Interactions of HRS-7535 With Acetaminophen, Digoxin, Rosuvastatin, and Omeprazole in Obese or Overweight Subjects
Shandong Suncadia Medicine Co., Ltd.·phase1·completed·n = 40
ObesityOverweightHRS-7535 TabletsParacetamol TabletsDigoxin TabletsRosuvastatin Calcium TabletsOmeprazole Enteric-coated Capsules
brief summary
This study is an open-label, fixed-sequence, self-controlled Phase I clinical trial conducted among obese or overweight subjects, with a planned enrollment of 40 adult subjects.
started
Dec 8, 2025
primary completion
Mar 8, 2026
completion
Mar 8, 2026
last updated
Apr 15, 2026
official title
An Open, Fixed-sequence, Self-controlled Pharmacokinetic Study to Evaluate the Drug Interactions of HRS-7535 With Acetaminophen, Digoxin, Rosuvastatin, and Omeprazole in Obese or Overweight Subjects
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol